Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43.4M
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
11.8M
-
Shares change
-
-2.15M
-
Total reported value, excl. options
-
$12.8M
-
Value change
-
-$1.53M
-
Put/Call ratio
-
0.05
-
Number of buys
-
27
-
Number of sells
-
-12
-
Price
-
$1.09
Significant Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q4 2024
65 filings reported holding CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share as of Q4 2024.
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.8M shares
of 43.4M outstanding shares and own 27.09% of the company stock.
Largest 10 shareholders include Bleichroeder LP (5M shares), VANGUARD GROUP INC (2.06M shares), BlackRock, Inc. (639K shares), GEODE CAPITAL MANAGEMENT, LLC (631K shares), Robertson Stephens Wealth Management, LLC (479K shares), Sigma Planning Corp (447K shares), Good Life Advisors, LLC (400K shares), BANK OF AMERICA CORP /DE/ (324K shares), ADVISORY RESEARCH INC (257K shares), and STIFEL FINANCIAL CORP (211K shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.